Skip to Content
Uncategorized

Selling Stem Cells

Californians are set to vote on a proposal to spend $300 million a year over the next 10 years for stem cell research. For some perspective on how big a deal this would be, the federal government spent $25 million…
September 20, 2004

Californians are set to vote on a proposal to spend $300 million a year over the next 10 years for stem cell research. For some perspective on how big a deal this would be, the federal government spent $25 million last year. The ballot measure, known as Proposition 71, is being financially supported by a strong cadre of entertainers, business people, and others, including Nancy Reagan, as the New York Times reports today and would be a strong counteraction to the Bush administration’s ban on new stem cell lines. But is the Times overstating the number of potential beneficiaries of stem cell research? The paper writes, “half of California’s families are affected by one or more of the 70 diseases or conditions that could respond to stem cell therapies,” in which they include Alzheimer’s disease. (Approximately 500,000 Californians have Alzheimer’s disease.) But as the Washington Post reported in June, stem cells are an unlikely therapy for Alzheimers, which involves the loss of huge numbers and varieties of the brain’s 100 billion nerve cells. Lest California voters come to wonder just what they’ve been sold, it may be better to be up front about it in the first place.

Keep Reading

Most Popular

The inside story of how ChatGPT was built from the people who made it

Exclusive conversations that take us behind the scenes of a cultural phenomenon.

How Rust went from a side project to the world’s most-loved programming language

For decades, coders wrote critical systems in C and C++. Now they turn to Rust.

Design thinking was supposed to fix the world. Where did it go wrong?

An approach that promised to democratize design may have done the opposite.

Sam Altman invested $180 million into a company trying to delay death

Can anti-aging breakthroughs add 10 healthy years to the human life span? The CEO of OpenAI is paying to find out.

Stay connected

Illustration by Rose Wong

Get the latest updates from
MIT Technology Review

Discover special offers, top stories, upcoming events, and more.

Thank you for submitting your email!

Explore more newsletters

It looks like something went wrong.

We’re having trouble saving your preferences. Try refreshing this page and updating them one more time. If you continue to get this message, reach out to us at customer-service@technologyreview.com with a list of newsletters you’d like to receive.